ARCH Venture Management as of March 31, 2023
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 8 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eqrx | 34.0 | $71M | 36M | 1.94 | |
| Denali Therapeutics (DNLI) | 28.6 | $59M | 2.6M | 23.04 | |
| Erasca (ERAS) | 16.1 | $33M | 11M | 3.01 | |
| Verve Therapeutics (VERV) | 14.0 | $29M | 2.0M | 14.42 | |
| Karuna Therapeutics Ord | 2.6 | $5.4M | 30k | 181.64 | |
| Singular Genomics Systems In | 2.2 | $4.6M | 3.8M | 1.21 | |
| Natera (NTRA) | 1.7 | $3.6M | 64k | 55.52 | |
| Unity Biotechnology (UBX) | 0.8 | $1.6M | 1.0M | 1.63 |
